| Literature DB >> 24934348 |
H Fu, H Fang, Jie Sun, H Wang, A Liu, J Sun, Z Wu1.
Abstract
Since Bortezomib was approved by US FDA as the first drug to treat multiple myeloma, various boronic acid compounds have been developed as enzyme inhibitors. This paper reviewed the progress of boronic acid-based inhibitors against enzymes including proteasome, serine protease, HDACs and other enzymes in the past decade.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24934348 DOI: 10.2174/0929867321666140601200803
Source DB: PubMed Journal: Curr Med Chem ISSN: 0929-8673 Impact factor: 4.530